Details
| Stereochemistry | MIXED |
| Molecular Formula | C19H40 |
| Molecular Weight | 268.5209 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)CCCC(C)CCCC(C)CCCC(C)C
InChI
InChIKey=XOJVVFBFDXDTEG-UHFFFAOYSA-N
InChI=1S/C19H40/c1-16(2)10-7-12-18(5)14-9-15-19(6)13-8-11-17(3)4/h16-19H,7-15H2,1-6H3
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Contribution of mast cell mediators to alterations in macrophage function after malathion administration. | 1996 Sep |
|
| Differential gene expression in pristane-induced arthritis susceptible DA versus resistant E3 rats. | 2003 |
|
| Degradation of alkanes and highly chlorinated benzenes, and production of biosurfactants, by a psychrophilic Rhodococcus sp. and genetic characterization of its chlorobenzene dioxygenase. | 2003 Oct |
|
| Prostaglandin E2 receptors EP2 and EP4 are up-regulated in peritoneal macrophages and joints of pristane-treated mice and modulate TNF-alpha and IL-6 production. | 2004 Jul |
|
| High prevalence of autoantibodies to RNA helicase A in Mexican patients with systemic lupus erythematosus. | 2010 |
|
| MicroRNA-26a negatively regulates toll-like receptor 3 expression of rat macrophages and ameliorates pristane induced arthritis in rats. | 2014 Jan 14 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C44351
Created by
admin on Sat Dec 16 20:09:06 GMT 2023 , Edited by admin on Sat Dec 16 20:09:06 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
53181
Created by
admin on Sat Dec 16 20:09:06 GMT 2023 , Edited by admin on Sat Dec 16 20:09:06 GMT 2023
|
PRIMARY | |||
|
C29850
Created by
admin on Sat Dec 16 20:09:06 GMT 2023 , Edited by admin on Sat Dec 16 20:09:06 GMT 2023
|
PRIMARY | NCIT | ||
|
26HZV48DT1
Created by
admin on Sat Dec 16 20:09:06 GMT 2023 , Edited by admin on Sat Dec 16 20:09:06 GMT 2023
|
PRIMARY | |||
|
8345
Created by
admin on Sat Dec 16 20:09:06 GMT 2023 , Edited by admin on Sat Dec 16 20:09:06 GMT 2023
|
PRIMARY | |||
|
DTXSID70870919
Created by
admin on Sat Dec 16 20:09:06 GMT 2023 , Edited by admin on Sat Dec 16 20:09:06 GMT 2023
|
PRIMARY | |||
|
m9140
Created by
admin on Sat Dec 16 20:09:06 GMT 2023 , Edited by admin on Sat Dec 16 20:09:06 GMT 2023
|
PRIMARY | Merck Index | ||
|
1921-70-6
Created by
admin on Sat Dec 16 20:09:06 GMT 2023 , Edited by admin on Sat Dec 16 20:09:06 GMT 2023
|
PRIMARY | |||
|
114852
Created by
admin on Sat Dec 16 20:09:06 GMT 2023 , Edited by admin on Sat Dec 16 20:09:06 GMT 2023
|
PRIMARY | |||
|
217-650-8
Created by
admin on Sat Dec 16 20:09:06 GMT 2023 , Edited by admin on Sat Dec 16 20:09:06 GMT 2023
|
PRIMARY | |||
|
15979
Created by
admin on Sat Dec 16 20:09:06 GMT 2023 , Edited by admin on Sat Dec 16 20:09:06 GMT 2023
|
PRIMARY | |||
|
C009042
Created by
admin on Sat Dec 16 20:09:06 GMT 2023 , Edited by admin on Sat Dec 16 20:09:06 GMT 2023
|
PRIMARY | |||
|
PRISTANE
Created by
admin on Sat Dec 16 20:09:06 GMT 2023 , Edited by admin on Sat Dec 16 20:09:06 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD
